Every year in the United States, Intensive Care Units (ICUs) admit millions of patients whose medications and fluids must be administered through intravenous (IV) therapy. Peripheral IVs (PIVs) are the most common invasive medical procedure, and more than 300 million IV catheters are sold in the U.S. every year.* But according to current medical reports, more than 20% of IVs fail because of infiltration.*

Both adult and pediatric ICU patients are particularly vulnerable to PIV complications, including infiltrations, because their illnesses are severe, and they may have lost their ability to communicate. Every infiltration is a medication dosing and delivery error that can prolong hospital stays, increase health care expenses, or cause additional patient harm. Any one of these may result in significant legal risk and reputation damage for healthcare providers.

A continuous monitoring device for peripheral IVs is the new and next step for minimizing this potential for patient harm. Immediate warning of infiltrations reduces the risk of injury to every patient with a peripheral IV.

Because this kind of device is always watching the IV site, it gives clinicians a reasonable and less intrusive alternative a central line, and significantly improves the security of a standard unmonitored PIV.

*Helm, R. E., Klausner, J.D., Klemperer, J.D., Flint, L.M., and Huang, E. (2015). “Accepted but Unacceptable: Peripheral IV Catheter Failure.” Journal of Infusion Nursing, 38(3), 189-203.